UBS Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Stifel Nicolaus Downgrades Auxilium Pharmaceuticals (AUXL) to Hold
September 22, 2014 6:48 AM EDTStifel Nicolaus downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Hold.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $31.14 yesterday.
... MoreGoldman Sachs Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
September 19, 2014 7:29 AM EDTGoldman Sachs downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
Analyst Gary Nachman said, "We downgrade AUXL to Neutral from Buy after ENDPs 9/16 offer to acquire AUXL for $28.10/share,... More
Endo's (ENDP) $2.2B Bid Undervalues Auxilium (AUXL) - Aegis Capital
September 17, 2014 9:01 AM EDTAegis Capital comments on Auxilium Pharma (Nasdaq: AUXL) following a $28.10 per share bid placed by Endo Pharma (Nasdaq: ENDP) on Tuesday night.
Analyst Raghuram Selvaraju commented, In our view, Endo is being opportunistic in the context of Auxilium's recent operational struggles, which began with the attrition seen in the testosterone... More
Auxilium (AUXL) Could Be Worth Up to $45/Share in a Potential Takeover - Jefferies
September 17, 2014 7:39 AM EDTJefferies analyst Thomas Wei weighed in on Auxilium Pharmaceuticals (NASDAQ: AUXL) after Endo offered to acquire the company for $28.10 per share. Wei sees more... More
Auxilium Pharma (AUXL) to Review Endo (ENDP) Bid; Adopts Poison Pill Provision
September 17, 2014 7:01 AM EDTAuxilium Pharma (NASDAQ: AUXL) confirmed that Auxilium has received an unsolicited, non-binding proposal from Endo International plc (NASDAQ: ENDP) to acquire all of the outstanding shares of Auxilium common stock at a price of $28.10 per share in cash and Endo stock, subject to due diligence, financing and other conditions. A copy of the unsolicited, non-binding proposal that Auxilium received from Endo on Friday evening is reproduced below. Click here to view the letter.
Consistent with its fiduciary duties and in accordance with its existing merger agreement with QLT... More
